Ahirrao, S. et al. 2022. Effective use of Silymarin as a promising P-Glycoprotein Inhibitor in the Management of Breast Cancer. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN). 15, 5 (Oct. 2022), 6147–6153. DOI:https://doi.org/10.37285/ijpsn.2022.15.5.6.